Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Mounjaro (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus in adults
Currently, people who took Ozempic and developed NAION cannot join the multidistrict litigation (group lawsuit) for people harmed by the drug
Common Diabetes Medications Used in Pregnancy Pregnant women with diabetes often need help to keep their blood sugar levels in a healthy range
BMC Med 23 , 398 (2025)
Discuss any changes with your healthcare provider
While headache is reported as an adverse reaction, it is not listed among the most common adverse events in the FDA Prescribing Information for Ozempic
US$ 27.69
US$ 20.28
US$ 22.11
US$ 24.98
US$ 21.24
US$ 29.76
